Clinical trial Recruiting at 1 site Phase 1 Interventional Ages 18 to 55

Using magnetic stimulation to treat headaches after concussions

Official title: Using Repetitive Transcranial Magnetic Stimulation to Manage Headaches and Improve Rehabilitation Outcomes in Mild Traumatic Brain Injury: A Longitudinal Study

Run by State University of New York - Upstate Medical University · NCT06112093 · Data updated 2026-11-12

This study is testing if a special type of brain stimulation can help people with chronic headaches after a concussion feel better without the side effects of regular medications.

Quick facts

PhasePhase 1
Study typeInterventional
Ages18 Years to 55 Years
SexAll
Enrollment60 (estimated)
SponsorState University of New York - Upstate Medical University
Academic / other
Locations1 site (Syracuse, New York)
StatusRecruiting
StartedOctober 23, 2023
Main results expectedOctober 23, 2026
Study endsOctober 23, 2027
Registry record updatedOctober 10, 2025
Trial IDNCT06112093 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18-55 who have experienced a mild traumatic brain injury and have persistent headaches that developed within a week of the injury.

Probably not a fit

Patients with a history of chronic headache disorders prior to their concussion may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study examines the long-term effects of repetitive transcranial magnetic stimulation (rTMS), a non-invasive brain stimulation technique, on chronic headaches that follow mild traumatic brain injury (mTBI). The approach aims to reduce headache symptoms without the side effects associated with traditional medications. Participants will receive either active rTMS or a sham treatment to assess the effectiveness of this intervention. The study also seeks to identify biomarkers that could aid in the diagnosis and prognosis of post-concussion symptoms.

Why it matters

Potential benefit: If successful, this treatment could significantly alleviate chronic headaches in patients recovering from concussions, improving their quality of life.

How similar studies have gone: Other studies have shown promising results with rTMS for headache management, indicating potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 18 - 55 years old
* mTBI with loss of consciousness for less than 30 min, initial Glasgow Coma Scale between 13 and 15, or post-traumatic amnesia for ≤ 24 hours
* diagnosis of persistent post-traumatic headache according to the International Classification of Headache Disorders, 3rd edition (ICHD-3) criteria
* headache develops within 7 days after head trauma
* headache persists for \>=3 months after head trauma despite receiving standard care
* average persistent headache intensity is \>= 3/10 of the numerical rating scale (NRS) on \>=3days/week
* no evidence of radiculopathy or peripheral neuropathy on electromyography or clinical evaluation
* no evidence of other possible causes of headaches

Exclusion Criteria:

* history of chronic headache diagnoses such as migraine, tension, or cluster headaches prior to the incidence of mTBI
* history of other neurologic conditions with medications affecting the central nervous system
* contraindications of receiving TMS (e.g., a history of epileptic seizure and having implants like a cardiac pacemaker or intracerebral vascular clip

Where it's running

  • SUNY Upstate Medical University
    Syracuse, New York, United States
    Recruiting

Study contacts

  • Principal investigator: Yi-Ling Kuo, PT, PhD — State University of New York - Upstate Medical University
  • Study coordinator: Yi-Ling Kuo, PT, PhD
  • Email: kuoy@upstate.edu
  • Phone: 3154646911

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.